XML 10 R4.htm IDEA: XBRL DOCUMENT v3.24.3
Unaudited Condensed Consolidated Statements of Operations and Other Comprehensive Loss - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Revenues        
Total Revenues $ 30 $ 0 $ 69 $ 75
Cost of revenues 1 0 3 0
Research and development expenses 984 1,335 2,386 3,001
Selling, general and administrative expenses 1,653 2,780 3,674 5,384
Total costs and expenses 2,638 4,115 6,063 8,385
Loss from Operations (2,608) (4,115) (5,994) (8,310)
Other Income        
Gain on investment in equity securities 0 0 0 12
Interest income 59 121 103 278
Total Other Income 59 121 103 290
Income Tax Expense 0 0 (2) (2)
Net Loss (2,549) (3,994) (5,893) (8,022)
Other Comprehensive loss:        
Unrealized gain (loss) on available-for-sale debt securities 1 (1) 1 (1)
Comprehensive Loss $ (2,548) $ (3,995) $ (5,892) $ (8,023)
Net loss per common share basic $ (0.14) $ (0.46) $ (0.36) $ (0.92)
Net loss per common share diluted $ (0.14) $ (0.46) $ (0.36) $ (0.92)
Weighted average shares used in computing net loss per common share basic 17,994,538 8,718,502 16,338,216 8,717,870
Weighted average shares used in computing net loss per common share diluted 17,994,538 8,718,502 16,338,216 8,717,870
Royalty Revenue [Member]        
Revenues        
Total Revenues $ 28 $ 0 $ 53 $ 75
Product Revenue [Member]        
Revenues        
Total Revenues $ 2 $ 0 $ 16 $ 0